NARA Discovery
Article Details
← Back to Search Results
Journal Article

How circadian variability of the heart rate and plasma electrolytes concentration influence the cardiac electrophysiology – model-based case study

Barbara Wiśniowska; Zofia M. Bielecka; Sebastian Polak
Journal of Pharmacokinetics and Pharmacodynamics · Vol. 48, Issue 3 · pp. 387-399 · 2021

Abstract

The circadian rhythm of cardiac electrophysiology is dependent on many physiological and biochemical factors. Provided, that models describing the circadian patterns of cardiac activity and/or electrophysiology which have been verified to the acceptable level, modeling and simulation can give answers to many of heart chronotherapy questions. The aim of the study was to assess the performance of the circadian models implemented in Cardiac Safety Simulator v 2.2 (Certara, Sheffield, UK) (CSS), as well as investigate the influence ofcircadian rhythms on the simulation results in terms of cardiac safety. The simulations which were run in CSS accounted for inter-individual and intra-individual variability. Firstly, the diurnal variations in QT interval length in a healthy population were simulated accounting for heart rate (HR) circadian changes alone, or with concomitant diurnal variations of plasma ion concentrations. Next, tolterodine was chosen as an exemplary drug for PKPD modelling exercise to assess the role of circadian rhythmicity in the prediction of drug effects on QT interval. The results of the simulations were in line with clinical observations, what can serve as a verification of the circadian models implemented in CSS. Moreover, the results have suggested that the circadian variability of the electrolytes balance is the main factor influencing QT circadian pattern. The fluctuation of ion concentration increases the intra-subject variability of predicted drug-triggered QT corrected for HR (QTc) prolongation effect and, in case of modest drug effect on QTc interval length, allows to capture this effect.

Bibliographic Information

JournalJournal of Pharmacokinetics and Pharmacodynamics
PublisherSpringer
Publication Date2021-06-01
Publication Year2021
Volume48
Issue3
Pages387-399
Document TypeJournal Article
Print ISSN1567-567X
eISSN1573-8744
DOI10.1007/s10928-021-09744-1

Access Information

NARA Access Coverage1973-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10928
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.